9 articles tagged with "biotech"
Recent findings suggest genetics may play a role in the effectiveness of GLP-1 treatments, raising questions about personalized approaches to diabetes care.
A small biotech company faced a critical setback due to a delayed agreement with the FDA, leading to its closure.
Strategic angle: Smaller biotechs negotiate with the White House while addressing the trust gap in medicine.
Strategic angle: Biogen and Eli Lilly make takeover moves, while Doctors Without Borders criticizes Gilead amidst growing concerns in the biotech sector.
Strategic angle: U.S. venture capital firms are proactively investing in Chinese biotech, shifting their strategy as competition intensifies.
Strategic angle: The White House shares legislative text on drug pricing with major pharmaceutical companies.
Strategic angle: How China's biotech boom is transforming the landscape of global science collaboration amidst an NIH crackdown.
Strategic angle: Eli Lilly discusses the 'societal obligation' of GLP-1s amidst other biotech news.
Strategic angle: A significant investment in a biotech stock following a major clinical success.